About Elisabethinen Hospital Linz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
4
AOP Orphan Pharmaceuticals AG
3
Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)
2
Astellas Pharma Inc
2
Boehringer Ingelheim
2
Boston Scientific Corporation
2
Elisabethinen Hospital
2
Hoffmann-La Roche
2
Medtronic BRC
2
Medtronic Cardiac Rhythm and Heart Failure
2
Merz Pharmaceuticals GmbH
2
Clinical Trials at Elisabethinen Hospital Linz
During the past decade, Elisabethinen Hospital Linz conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 18 clinical trials were completed, i.e. on
average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of FK463 for the Treatment of Invasive Aspergillosis
1999-01-29
2002-01-31
Completed
326
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
1999-02-27
2002-01-27
Completed
75
Efficacy of a Pacemaker Algorithm in Promotion of the Intrinsic Heart Activity.
2004-04-01
2006-04-01
Unknown status
150
A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
2006-03-01
2009-06-01
Completed
436
2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
2008-04-01
2014-12-01
Completed
564
Catheter Ablation vs. Standard Conventional Treatment in Patients With LV Dysfunction and AF
2008-01-01
2017-03-01
Completed
398
Feature Assessment Study for Indications Based Programming
2008-06-01
2010-02-01
Completed
301
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Elisabethinen Hospital Linz" #1 sponsor was "Celgene" with 4 trials, followed by "AOP Orphan Pharmaceuticals AG" with 3 trials
sponsored, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 2 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored and "Boehringer Ingelheim"
with 2 trials sponsored. Other sponsors include 26 different institutions and
companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Elisabethinen Hospital Linz"
#1 collaborator was "Elisabethinen Hospital" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Democritus University of Thrace" with 1 trials as a collaborator and "Erasmus Medical Center" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at Elisabethinen Hospital Linz
According to Clinical.Site data, the most researched conditions in "Elisabethinen Hospital Linz" are
"Pulmonary Arterial Hypertension" (4 trials), "Atrial Fibrillation" (3 trials), "Heart Failure" (3 trials), "Multiple Myeloma" (3 trials) and "Polycythemia Vera" (3 trials). Many other conditions were trialed in "Elisabethinen Hospital Linz" in a lesser frequency.
Clinical Trials Intervention Types at Elisabethinen Hospital Linz
Most popular intervention types in "Elisabethinen Hospital Linz" are "Drug" (28 trials), "Other" (8 trials), "Device" (7 trials), "Procedure" (5 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Azacitidine" (2 trials), "FK463" (2 trials), "Neramexane mesylate" (2 trials) and "Sotatercept" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Elisabethinen Hospital Linz
The vast majority of trials in "Elisabethinen Hospital Linz" are
44 trials for "All" genders.
Clinical Trials Status at Elisabethinen Hospital Linz
Currently, there are NaN active trials in "Elisabethinen Hospital Linz".
undefined are not yet recruiting,
2 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 30 completed trials in Elisabethinen Hospital Linz,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Elisabethinen Hospital Linz, 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 6 trials that are defined as “Not Applicable".